13th Apr 2026 15:29
Hikma Pharmaceuticals PLC - EIP Vesting
LONDON, 13 April 2026: Hikma Pharmaceuticals PLC (LSE: HIK) (Nasdaq Dubai: HIK) ("Hikma") (LEI: 549300BNS685UXH4JI75) announces that the following Persons Discharging Managerial Responsibility ("PDMRs") have received shares as a result of the vesting of their conditional share awards which were granted on 9 April 2024 under the 2023 Long-Term Incentive Plan ("LTIP").
Notification and public disclosure of transactions by persons discharging managerial responsibilities
Julie Hill
1 | Details of the person discharging managerial responsibilities / person closely associated | ||
a) | Name | Julie Hill | |
2 | Reason for the notification | ||
a) | Position/status | PDMR | |
b) | Initial notification /Amendment | Initial notification | |
3 | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | ||
a) | Name | Hikma Pharmaceuticals PLC | |
b) | LEI | 549300BNS685UXH4JI75 | |
4 | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | ||
a) | Description of the financial instrument, type of instrument and identification code | Description: Ordinary shares of 10 pence each ("Shares") ID Code: GB00B0LCW083 | |
b) | Nature of the transaction | Shares acquired from the vesting of conditional awards under the LTIP. | |
c) | Price(s) and volume(s) | Price(s) | Volume(s) |
Nil | 8,188 | ||
d) | Aggregated information | Price(s): nil Volume(s): 8,188 | |
e) | Date of the transaction | 9 April 2026 | |
f) | Place of the transaction | London Stock Exchange (XLON) | |
4 | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | ||
a) | Description of the financial instrument, type of instrument and identification code | Description: Ordinary shares of 10 pence each ("Shares") ID Code: GB00B0LCW083 | |
b) | Nature of the transaction | Shares sold to cover tax following the vesting of conditional awards under the LTIP. | |
c) | Price(s) and volume(s) | Price(s) | Volume(s) |
£13.09 | 3,121 | ||
d) | Aggregated information | Price(s): £13.09 Volume(s): 3,121 Total(s): £40,851.53 | |
e) | Date of the transaction | 9 April 2026 | |
f) | Place of the transaction | London Stock Exchange (XLON) | |
Sam Park
1 | Details of the person discharging managerial responsibilities / person closely associated | ||
a) | Name | Sam Park | |
2 | Reason for the notification | ||
a) | Position/status | PDMR | |
b) | Initial notification /Amendment | Initial notification | |
3 | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | ||
a) | Name | Hikma Pharmaceuticals PLC | |
b) | LEI | 549300BNS685UXH4JI75 | |
4 | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | ||
a) | Description of the financial instrument, type of instrument and identification code | Description: Ordinary shares of 10 pence each ("Shares") ID Code: GB00B0LCW083 | |
b) | Nature of the transaction | Shares acquired from the vesting of conditional awards under the LTIP. | |
c) | Price(s) and volume(s) | Price(s) | Volume(s) |
Nil | 19,045 | ||
d) | Aggregated information | Price(s): nil Volume(s): 19,045 | |
e) | Date of the transaction | 9 April 2026 | |
f) | Place of the transaction | London Stock Exchange (XLON) | |
4 | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | ||
a) | Description of the financial instrument, type of instrument and identification code | Description: Ordinary shares of 10 pence each ("Shares") ID Code: GB00B0LCW083 | |
b) | Nature of the transaction | Shares sold to cover tax following the vesting of conditional awards under the LTIP. | |
c) | Price(s) and volume(s) | Price(s) | Volume(s) |
£13.09 | 7,259 | ||
d) | Aggregated information | Price(s): £13.09 Volume(s): 7,259 Total(s): £95,014.82 | |
e) | Date of the transaction | 9 April 2026 | |
f) | Place of the transaction | London Stock Exchange (XLON) | |
Helen MiddlemistGroup Company Secretary
+44 (0)20 7399 2760
Related Shares:
Hikma Pharmaceuticals